Aceragen Inc
ACGN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.24M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.24 Million |
|---|---|
| Enterprise Value | $1.67 Million |
| Earnings per Share | $-7.17 |
| Beta | 1.14 |
| Outstanding Shares | 5,352,900 |
Return
| Return on Equity | -49.27% |
|---|---|
| Return on Assets | -18.97% |
| Return on Invested Capital | -9.31% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | 0.34 |
| Enterprise Value to EBIT | -0.22 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 6.28 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aceragen Inc
32 employees
CEO: Vincent Milano
Harnessing the approach of the earliest researchers in immunotherapy and the company's vast experience in developing proprietary immunology platforms, Idera's development program is focused on priming the immune system to play a more pow...